美国保险对大隐静脉和小隐静脉曲张腔内消融术的覆盖情况
该横断面分析评估了57份腔内激光/射频消融保险政策,其中36份(63.2%)覆盖该手术。覆盖指征共6种,最常见为瓣膜反流(n=29,80.6%),其中19份(52.8%)特别要求大隐静脉反流。高达33%的保险公司要求术前尝试保守治疗。
要点
- 57份保险政策中36份(63.2%)覆盖腔内激光/射频消融。
- 29份覆盖瓣膜反流的政策中19份(52.8%)特别要求大隐静脉反流。
- 要求大隐静脉反流者显著多于其他类型瓣膜反流(52.8% vs 8.3%,P<0.001)。
核心结论
- 保险政策对腔内激光/射频消融治疗曲张静脉的覆盖标准存在很大差异,尤其在瓣膜反流要求和保守治疗试验方面。
研究设计与样本
- 横断面分析,基于最大州参保人数和市场份额选取57份腔内激光/射频消融保险政策,通过网页检索和电话访谈识别,从公开政策中提取医学必要标准。
主要发现
- 57份保险政策中36份(63.2%)覆盖腔内射频或激光消融。
- 覆盖指征共6种,最常见为瓣膜反流(n=29,80.6%)。
- 29份覆盖瓣膜反流的公司中19份(52.8%)特别要求大隐静脉反流。
- 要求大隐静脉反流者显著多于交界处反流(52.8% vs 8.3%,P<0.001)和非特异性反流(52.8% vs 16.7%,P<0.003)。
- 高达33%的保险公司要求术前尝试保守治疗作为医学必要。
关键数值与推荐
- 覆盖指征共6种,最常见为瓣膜反流(n=29,80.6%)。
- 29份覆盖瓣膜反流的公司中19份(52.8%)特别要求大隐静脉反流。
- 要求大隐静脉反流者显著多于交界处反流(52.8% vs 8.3%,P<0.001)和非特异性反流(52.8% vs 16.7%,P<0.003)。
- 高达33%的保险公司要求术前尝试保守治疗。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Severe cases of varicose veins can cause psychological distress as well as physical symptoms including skin discoloration, wounds, and burning sensations. One intervention, endovenous laser/radiofrequency ablation, is variably covered by insurance. Insurance coverage for this procedure was assessed for all indications of endovenous laser/radiofrequency ablation as medically necessity criteria. METHODS: A cross-sectional analysis was conducted of 57 insurance policies for endovenous laser/radiofrequency ablation. The insurance companies were selected based on the greatest state enrollment and market share. A web-based search and telephone interviews were utilized to identify the policies. Medically necessary criteria were then extracted from the publicly available policies. RESULTS: Fifty-seven (57) insurance policies were assessed, with 36 (63.2%) of these policies providing coverage for endovenous radiofrequency or laser ablation. Six indications existed for coverage, with the most common indication being the demonstration of valvular reflux (n = 29, 80.6%). Of the 29 companies that indicated coverage for valvular reflux, 19 (52.8%) specifically required saphenous reflux. Significantly more companies required saphenous reflux versus other specified types of valvular reflux (52.8% vs 8.3%, P < 0.001 for saphenous vs junctional reflux and 52.8% vs 16.7%, P < 0.003 for saphenous vs nonspecific). Prior to proceeding with endovenous laser or radiofrequency ablation, up to 33% of insurance companies required a trial of conservative management as medically necessary. CONCLUSIONS: There is a great discrepancy in insurance policy criteria for coverage of endovenous laser/radiofrequency ablation for the treatment of varicose veins, particularly regarding the requirements for valvular reflux and a trial of conservative therapy.
引用
- Onyima C, Hricz N, Zhu K, et al. American Insurance Coverage of Endovenous Ablation for Greater and Lesser Saphenous Varicose Veins. Ann Vasc Surg. 2024. PMID: 39029894. doi:10.1016/j.avsg.2024.06.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。